Fagron N.V. : Fagron receives three FDA warnings in Minnesota E&B facility
>Fagron actions on three out of seven observations insufficient - Yesterday, the FDA announced that it has sent a warning letter to Fagron on 14 June containing three warnings concerning the company’s Minnesota Essentials & Brands facility. The FDA summarises three deviations from current good manufacturing practice (CGMP) in Fagron’s oldest US facility, after the regulator found seven observations in November 2021. In short, Fagron argues that it has updated and chan...Fagron supplies products, services to professionals and institutions in the healthcare sector in Europe, the U.S.A. and Brazil. Co.'s activities are subdivided into four divisions. Through Fagron, Co. offers products and concepts for pharmaceutical compounding. Through Arseus Dental, Co. supplies dental products and concepts to dentists and dental laboratories in Belgium, the Netherlands, France, Germany and Switzerland. Through Arseus Medical, Co. supplies medical and surgical products to specialists, elderly homes, homecare nurses and hospitals in Belgium and the Netherlands. Through Corilus, Co. supplies ICT total solutions for medical specialists in Belgium, the Netherlands and France.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.